We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Optoacoustic Imaging Augments Breast Mass Assessment

By MedImaging International staff writers
Posted on 06 Jun 2018
Print article
Image: A novel breast imaging system fuses optoacoustics and ultrasound (Photo courtesy of Seno Medical).
Image: A novel breast imaging system fuses optoacoustics and ultrasound (Photo courtesy of Seno Medical).
A novel breast imaging system fuses optoacoustic (OA) and ultrasound (US) technologies to generate real-time functional and anatomical images of the breast.

The Seno Medical Instruments (San Antonio, TX, USA) Imagio OA/US breast imaging system uses OA to provide a “blood map” around breast masses, while US provides a traditional anatomic image. Unlike current techniques that create images by transmitting and receiving energy in the same form, OA/US imaging transmits photonic energy, but detects acoustic energy; by transmitting multiple bandwidths of laser light, a much broader range of data can be captured, which makes the functional images possible.

The system can thus detect the appearance (or absence) of two of the hallmark indicators of cancer, angiogenesis and deoxygenation, by measuring hemoglobin concentration in the breast tissues. The resulting amalgamation of data helps radiologists confirm or rule out malignancy with more certainty than current diagnostic imaging modalities, and without exposing patients to potentially harmful ionizing X-ray radiation or contrast agents.

A study by researchers at the Northwestern University (NU; Chicago, IL, USA) and other institutions involving 2,105 women conducted to compare the diagnostic utility of the Imagio OA/US breast imaging system to grayscale US alone, found that OA/US downgraded 40.8% of benign mass reads, with a specificity of 43%, compared to 28.1% for grayscale US alone, resulting in a need for fewer subsequent needle biopsies. The study was published in the May 2018 issue of Radiology.

“Needle biopsies are expensive, very stressful to the patient, often require another appointment for the patient, and it can take days to get the results. Patients who are safely downgraded to not needing a biopsy would benefit,” said Stephen Grobmyer, MD, of the Cleveland Clinic (OH, USA) Comprehensive Breast Cancer Program. “Safely reducing the number of breast biopsy procedures through advanced imaging would add a lot of value to the current system. It also may help identify lesions that require biopsy that were thought to be benign by traditional imaging.”

OA is a biomedical imaging modality based on the photoacoustic effect, which results of some of the delivered energy absorbed and converted into heat, leading to transient thermoelastic expansion and thus wideband US emission. As optical absorption is closely associated with physiological properties, such as hemoglobin concentration and oxygen saturation, the magnitude of the US emission reveals physiologically specific optical absorption contrast, allowing 2D or 3D images of the targeted areas to be formed.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Calibration Electrometer
PC Electrometer
Under Table Shield
3 Section Double Pivot Under Table Shield
Mammography System
MAMMOVISTA B.smart

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.